Moderna (MRNA) call put ratio 2.4 calls to 1 put after Phase 1 coronavirus vaccine data

Moderna (NASDAQ: MRNA) May weekly call option implied volatility is at 216, June is at 133; compared to its 52-week range of 50 to 172 after Moderna said its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients.

You May Also Be Interested In

• Moderna (MRNA) PT Raised to $45 at RBC Capital
• T-Mobile (TMUS) call put ratio 2.8 calls to 1 put with a focus on July 195 calls
• Sandisk (SNDK) call put ratio 1 call to 1.1 puts